Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 186

  • The following terms were ignored: ), )
  • See the search details.
1.

Towards a more precise diagnosis of hypersensitivity to beta-lactams - an EAACI position paper.

Romano A, Atanaskovic-Markovic M, Barbaud A, Bircher AJ, Brockow K, Caubet JC, Celik G, Cernadas J, Chiriac AM, Demoly P, Garvey LH, Mayorga C, Nakonechna A, Whitaker P, Torres MJ.

Allergy. 2019 Nov 21. doi: 10.1111/all.14122. [Epub ahead of print]

PMID:
31749148
2.

Cystic Fibrosis Diagnosis in Newborns, Children, and Adults.

Castellani C, Linnane B, Pranke I, Cresta F, Sermet-Gaudelus I, Peckham D.

Semin Respir Crit Care Med. 2019 Dec;40(6):701-714. doi: 10.1055/s-0039-1697961. Epub 2019 Nov 3.

PMID:
31679154
3.

ENaC-mediated sodium influx exacerbates NLRP3-dependent inflammation in cystic fibrosis.

Scambler T, Jarosz-Griffiths HH, Lara-Reyna S, Pathak S, Wong C, Holbrook J, Martinon F, Savic S, Peckham D, McDermott MF.

Elife. 2019 Sep 18;8. pii: e49248. doi: 10.7554/eLife.49248.

4.

Definition of Haptens Derived from Sulfamethoxazole: In Vitro and in Vivo.

Tailor A, Waddington JC, Hamlett J, Maggs J, Kafu L, Farrell J, Dear GJ, Whitaker P, Naisbitt DJ, Park K, Meng X.

Chem Res Toxicol. 2019 Oct 21;32(10):2095-2106. doi: 10.1021/acs.chemrestox.9b00282. Epub 2019 Sep 11.

PMID:
31468968
5.

Metabolic Reprograming of Cystic Fibrosis Macrophages via the IRE1α Arm of the Unfolded Protein Response Results in Exacerbated Inflammation.

Lara-Reyna S, Scambler T, Holbrook J, Wong C, Jarosz-Griffiths HH, Martinon F, Savic S, Peckham D, McDermott MF.

Front Immunol. 2019 Aug 2;10:1789. doi: 10.3389/fimmu.2019.01789. eCollection 2019.

6.

Editorial: Advances in drug hypersensitivity reactions.

Blanca M, Whitaker P.

Curr Opin Allergy Clin Immunol. 2019 Aug;19(4):263-265. doi: 10.1097/ACI.0000000000000554. No abstract available.

PMID:
31169595
7.

Serum IgE and IgG reactivity to Aspergillus recombinant antigens in patients with cystic fibrosis.

Alghamdi NS, Barton R, Wilcox M, Peckham D.

J Med Microbiol. 2019 Jun;68(6):924-929. doi: 10.1099/jmm.0.000991. Epub 2019 May 15.

8.

Assessing arthritis in the context of cystic fibrosis.

Clarke EA, Watson P, Freeston JE, Peckham DG, Jones AM, Horsley A.

Pediatr Pulmonol. 2019 Jun;54(6):770-777. doi: 10.1002/ppul.24290. Epub 2019 Mar 5. Review.

PMID:
30838784
9.

Use of ceftazidime/avibactam for the treatment of MDR Pseudomonas aeruginosa and Burkholderia cepacia complex infections in cystic fibrosis: a case series.

Spoletini G, Etherington C, Shaw N, Clifton IJ, Denton M, Whitaker P, Peckham DG.

J Antimicrob Chemother. 2019 May 1;74(5):1425-1429. doi: 10.1093/jac/dky558.

PMID:
30649419
10.

A EAACI drug allergy interest group survey on how European allergy specialists deal with β-lactam allergy.

Torres MJ, Celik GE, Whitaker P, Atanaskovic-Markovic M, Barbaud A, Bircher A, Blanca M, Brockow K, Caubet JC, Cernadas JR, Chiriac A, Demoly P, Garvey LH, Merk HF, Mosbech H, Nakonechna A, Romano A.

Allergy. 2019 Jun;74(6):1052-1062. doi: 10.1111/all.13721. Epub 2019 Feb 17.

PMID:
30637768
11.

Respiratory morbidity in young people surviving cancer: Population-based study of hospital admissions, treatment-related risk factors and subsequent mortality.

Smith L, Glaser AW, Peckham D, Greenwood DC, Feltbower RG.

Int J Cancer. 2019 Jul 1;145(1):20-28. doi: 10.1002/ijc.32066. Epub 2019 Jan 16.

12.

Level of accuracy of diagnoses recorded in discharge summaries: A cohort study in three respiratory wards.

Tsopra R, Wyatt JC, Beirne P, Rodger K, Callister M, Ghosh D, Clifton IJ, Whitaker P, Peckham D.

J Eval Clin Pract. 2019 Feb;25(1):36-43. doi: 10.1111/jep.13020. Epub 2018 Aug 14.

13.

Management of adverse reactions to first-line tuberculosis antibiotics.

Nagarajan S, Whitaker P.

Curr Opin Allergy Clin Immunol. 2018 Aug;18(4):333-341. doi: 10.1097/ACI.0000000000000462. Review.

PMID:
29901473
14.

Advances in hypersensitivity drug reactions.

Blanca M, Whitaker P.

Curr Opin Allergy Clin Immunol. 2018 Aug;18(4):281-283. doi: 10.1097/ACI.0000000000000460. No abstract available.

PMID:
29889139
15.

The impact of three discharge coding methods on the accuracy of diagnostic coding and hospital reimbursement for inpatient medical care.

Tsopra R, Peckham D, Beirne P, Rodger K, Callister M, White H, Jais JP, Ghosh D, Whitaker P, Clifton IJ, Wyatt JC.

Int J Med Inform. 2018 Jul;115:35-42. doi: 10.1016/j.ijmedinf.2018.03.015. Epub 2018 Mar 27.

PMID:
29779718
16.

Autoinflammatory disease in the lung.

Scambler T, Holbrook J, Savic S, McDermott MF, Peckham D.

Immunology. 2018 Apr 19. doi: 10.1111/imm.12937. [Epub ahead of print] Review.

17.

Intravenous fosfomycin for pulmonary exacerbation of cystic fibrosis: Real life experience of a large adult CF centre.

Spoletini G, Kennedy M, Flint L, Graham T, Etherington C, Shaw N, Whitaker P, Denton M, Clifton I, Peckham D.

Pulm Pharmacol Ther. 2018 Jun;50:82-87. doi: 10.1016/j.pupt.2018.04.007. Epub 2018 Apr 13.

18.

Up-Regulation of T-Cell Activation MicroRNAs in Drug-Specific CD4+ T-Cells from Hypersensitive Patients.

Monroy-Arreola A, Durán-Figueroa NV, Méndez-Flores S, Domínguez-Cherit J, Watkinson J, Badillo-Corona JA, Whitaker P, Naisbitt DJ, Castrejón-Flores JL.

Chem Res Toxicol. 2018 Jun 18;31(6):454-461. doi: 10.1021/acs.chemrestox.7b00330. Epub 2018 May 16.

PMID:
29644860
19.

Cytomegalovirus-associated pulmonary exacerbation in patients with cystic fibrosis.

Sawant A, Spoletini G, Whitaker P, Etherington C, Clifton I, Peckham D.

ERJ Open Res. 2018 Jan 10;4(1). pii: 00111-2017. doi: 10.1183/23120541.00111-2017. eCollection 2018 Jan.

20.

Assessment of Antipiperacillin IgG Binding to Structurally Related Drug Protein Adducts.

Amali MO, Jenkins RE, Meng X, Faulkner L, Whitaker P, Peckham D, Park BK, Naisbitt DJ.

Chem Res Toxicol. 2017 Dec 18;30(12):2097-2099. doi: 10.1021/acs.chemrestox.7b00291. Epub 2017 Nov 22.

PMID:
29148816

Supplemental Content

Loading ...
Support Center